Mead Johnson Nutrition’s “Outperform” Rating Reaffirmed at Credit Suisse (MJN)
Mead Johnson Nutrition (NYSE:MJN)‘s stock had its “outperform” rating reaffirmed by stock analysts at Credit Suisse in a report issued on Thursday, Analyst Ratings.Net reports.
The analysts wrote, “We recently attended meetings in China with Mead management. While the company is still struggling to get its arms around the volatility in the Chinese market, we continue to believe that there is some upside to consensus estimates owing to share gains from the temporary recall of competitors Danone and Abbott. This ‘gift’ along with the easy comparisons to last year’s missteps will give the stock some cover over the next two quarters while the Chinese market stabilizes.”
MJN has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. upgraded shares of Mead Johnson Nutrition (NYSE:MJN) from a “neutral” rating to an “overweight” rating in a research note to investors on Tuesday, September 17th. They now have a $88.00 price target on the stock, up previously from $78.00. Separately, analysts at First Global initiated coverage on shares of Mead Johnson Nutrition (NYSE:MJN) in a research note to investors on Tuesday, September 3rd. They set a “market perform” rating on the stock. Finally, analysts at Zacks upgraded shares of Mead Johnson Nutrition (NYSE:MJN) from an “underperform” rating to a “neutral” rating in a research note to investors on Monday, August 19th. They now have a $77.10 price target on the stock. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $80.65.
Shares of Mead Johnson Nutrition (NYSE:MJN) traded down 0.34% on Thursday, hitting $74.00. 390,931 shares of the company’s stock traded hands. Mead Johnson Nutrition has a 52 week low of $61.27 and a 52 week high of $86.87. The stock has a 50-day moving average of $75.75 and a 200-day moving average of $77.41. The company has a market cap of $14.977 billion and a price-to-earnings ratio of 24.92.
Mead Johnson Nutrition (NYSE:MJN) last announced its earnings results on Thursday, July 25th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the company posted $0.83 earnings per share. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. Analysts expect that Mead Johnson Nutrition will post $3.26 EPS for the current fiscal year.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.